ES2349110T5
(es)
|
2004-12-20 |
2013-11-27 |
Genentech, Inc. |
Inhibidores de IAP derivados de pirrolidina
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8303944B2
(en)
*
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8329159B2
(en)
*
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7745636B2
(en)
|
2006-08-11 |
2010-06-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2008070447A2
(en)
*
|
2006-11-21 |
2008-06-12 |
Smithkline Beecham Corporation |
Anti-viral compounds
|
TWI432212B
(zh)
*
|
2007-04-30 |
2014-04-01 |
Genentech Inc |
Iap抑制劑
|
MX2009011930A
(es)
|
2007-05-04 |
2009-11-18 |
Vertex Pharma |
Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
ITMI20071012A1
(it)
*
|
2007-05-18 |
2008-11-19 |
St Microelectronics Srl |
Dispositivo di memoria migliorato a veloce programmazione
|
US7858666B2
(en)
|
2007-06-08 |
2010-12-28 |
Mannkind Corporation |
IRE-1α inhibitors
|
BRPI0813999A2
(pt)
*
|
2007-07-05 |
2019-10-01 |
Array Biopharma Inc |
ciclopentanos de pirimidil como inibidores de akt proteína cinase
|
US7728027B2
(en)
*
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
US8629171B2
(en)
*
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
NZ583970A
(en)
|
2007-10-11 |
2011-04-29 |
Univ California |
Compositions and methods of inhibiting n-acylethanolamine-hydrolyzing acid amidase
|
DK2250163T3
(da)
*
|
2008-02-12 |
2012-07-16 |
Bristol Myers Squibb Co |
Hepatitis C-virusinhibitorer
|
MX2010008699A
(es)
|
2008-02-12 |
2010-08-30 |
Bristol Myers Squibb Co |
Derivados heterociclicos como inhibidores de virus de la hepatitis c.
|
BRPI0822323A2
(pt)
*
|
2008-02-13 |
2015-06-16 |
Bristol Myers Squibb Co |
Imidazolil bifenil imidazóis como inibidores do vírus da hepatite c
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7704992B2
(en)
*
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2318395A4
(de)
|
2008-08-02 |
2011-10-26 |
Genentech Inc |
Iap-hemmer
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TWI480272B
(zh)
*
|
2008-10-09 |
2015-04-11 |
Anadys Pharmaceuticals Inc |
藉由5,6-二氫-1h-吡啶-2-酮與一或多種其他抗病毒化合物的組合物抑制c型肝炎病毒的方法
|
WO2010065668A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
PT2373172E
(pt)
|
2008-12-03 |
2013-10-21 |
Presidio Pharmaceuticals Inc |
Inibidores de ns5a de hcv
|
WO2010075376A2
(en)
*
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
CA2740195A1
(en)
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
EP2393359A4
(de)
*
|
2009-02-09 |
2012-10-03 |
Enanta Pharm Inc |
Verbundene dibenzimidazolderivate
|
US8637561B2
(en)
|
2009-02-17 |
2014-01-28 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole derivatives
|
US8420686B2
(en)
|
2009-02-17 |
2013-04-16 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole antivirals
|
US8188132B2
(en)
|
2009-02-17 |
2012-05-29 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
US8394968B2
(en)
|
2009-02-17 |
2013-03-12 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8242156B2
(en)
|
2009-02-17 |
2012-08-14 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
TWI438200B
(zh)
*
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
EP2398474A4
(de)
*
|
2009-02-23 |
2012-12-05 |
Presidio Pharmaceuticals Inc |
Hcv-ns5a-shemmer
|
UY32462A
(es)
|
2009-02-23 |
2010-09-30 |
Arrow Therapeutics Ltd |
Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644
|
WO2010099527A1
(en)
*
|
2009-02-27 |
2010-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
US10752611B2
(en)
|
2009-02-27 |
2020-08-25 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
US9765087B2
(en)
|
2009-02-27 |
2017-09-19 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
US8426458B2
(en)
|
2009-02-27 |
2013-04-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C Virus inhibitors
|
US8673954B2
(en)
|
2009-02-27 |
2014-03-18 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
US8101643B2
(en)
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
US8507522B2
(en)
|
2009-03-06 |
2013-08-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2010111673A1
(en)
|
2009-03-27 |
2010-09-30 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic hcv inhibitors
|
KR20110131312A
(ko)
*
|
2009-03-27 |
2011-12-06 |
프레시디오 파마슈티칼스, 인코포레이티드 |
융합된 고리 c형 간염 억제제
|
TWI476190B
(zh)
*
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TW201038559A
(en)
*
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2419404B1
(de)
*
|
2009-04-15 |
2015-11-04 |
AbbVie Inc. |
Anti virale verbindungen
|
CA2759142A1
(en)
*
|
2009-04-24 |
2010-10-28 |
Tibotec Pharmaceuticals |
Diaryl ethers
|
WO2010132538A1
(en)
*
|
2009-05-12 |
2010-11-18 |
Schering Corporation |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
NZ706236A
(en)
*
|
2009-05-13 |
2016-07-29 |
Gilead Pharmasset Llc |
Antiviral compounds
|
AU2014203349B2
(en)
*
|
2009-05-13 |
2014-11-27 |
Gilead Sciences, Inc. |
Antiviral compounds
|
AU2013202666B2
(en)
*
|
2009-05-13 |
2015-07-16 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
AU2010253791A1
(en)
*
|
2009-05-29 |
2011-11-24 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three linked Aryl moieties to treat diseases such as Hepatitis C
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP2435421A1
(de)
*
|
2009-05-29 |
2012-04-04 |
Schering Corporation |
Aus drei in einer reihe ausgerichteten aryleinheiten zusammengesetzte antivirale verbindungen zur behandlung von krankheiten wie hepatitis c
|
AU2012203474B2
(en)
*
|
2009-06-11 |
2014-09-18 |
Abbvie Ireland Unlimited Company |
Anti-Viral Compounds
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
US8716454B2
(en)
|
2009-06-11 |
2014-05-06 |
Abbvie Inc. |
Solid compositions
|
US8937150B2
(en)
*
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
DK2455376T3
(en)
*
|
2009-06-11 |
2015-03-02 |
Abbvie Bahamas Ltd |
Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8609648B2
(en)
|
2009-07-02 |
2013-12-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2011009084A2
(en)
|
2009-07-16 |
2011-01-20 |
Vertex Pharmaceuticals Incorporated |
Benzimidazole analogues for the treatment or prevention of flavivirus infections
|
US8623899B2
(en)
|
2009-08-07 |
2014-01-07 |
Janssen Research & Development Ireland |
Bis-benzimidazole derivatives as hepatitis C virus inhibitors
|
CA2768637A1
(en)
|
2009-08-07 |
2011-02-10 |
Tibotec Pharmaceuticals |
Phenyl ethynyl derivatives as hepatitis c virus inhibitors
|
BR112012004969A2
(pt)
|
2009-09-03 |
2019-09-24 |
Tibotec Pharm Ltd |
derivados de bis-benzimidazol
|
WO2011028596A1
(en)
|
2009-09-04 |
2011-03-10 |
Glaxosmithkline Llc |
Chemical compounds
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2011031904A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
US8703938B2
(en)
*
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8822700B2
(en)
*
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8927709B2
(en)
*
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2011031934A1
(en)
*
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
US8759332B2
(en)
*
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8415374B2
(en)
|
2009-10-12 |
2013-04-09 |
Bristol-Myers Squibb Company |
Combinations of hepatitis C virus inhibitors
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
US20110269956A1
(en)
*
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110274648A1
(en)
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110281910A1
(en)
*
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
EP2503881B1
(de)
|
2009-11-25 |
2015-05-13 |
Merck Sharp & Dohme Corp. |
Kondensierte trizyklische verbindungen und derivate davon zur behandlung von virenerkrankungen
|
US20110137633A1
(en)
*
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Anti-viral compounds and methods of identifying the same
|
JP5753185B2
(ja)
*
|
2009-12-04 |
2015-07-22 |
ナショナル ヘルス リサーチ インスティテューツ |
プロリン誘導体
|
WO2011081918A1
(en)
|
2009-12-14 |
2011-07-07 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
US8377980B2
(en)
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2784646A1
(en)
|
2009-12-18 |
2011-06-23 |
Boehringer Ingelheim International Gmbh |
Hcv combination therapy
|
MX2012006877A
(es)
*
|
2009-12-18 |
2012-08-31 |
Idenix Pharmaceuticals Inc |
Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
|
CN104530079B
(zh)
*
|
2009-12-18 |
2017-10-20 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
CA2785488A1
(en)
|
2009-12-22 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
US20130072523A1
(en)
*
|
2009-12-24 |
2013-03-21 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8933110B2
(en)
|
2010-01-25 |
2015-01-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8785487B2
(en)
|
2010-01-25 |
2014-07-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2011091532A1
(en)
*
|
2010-01-28 |
2011-08-04 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
US8178531B2
(en)
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
US8623814B2
(en)
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
CA2791630A1
(en)
|
2010-03-04 |
2011-09-09 |
Enanta Pharmaceuticals, Inc. |
Combination pharmaceutical agents as inhibitors of hcv replication
|
AU2011224698A1
(en)
|
2010-03-09 |
2012-11-01 |
Merck Sharp & Dohme Corp. |
Fused Tricyclic Silyl Compounds and methods of use thereof for the treatment of viral diseases
|
TW201141857A
(en)
*
|
2010-03-24 |
2011-12-01 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
CA2794145A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
MX2012010919A
(es)
*
|
2010-03-24 |
2013-02-01 |
Vertex Pharma |
Analogos para el tratamiento o prevencion de infecciones por flavivirus.
|
UY33310A
(es)
|
2010-03-31 |
2011-10-31 |
Pharmasset Inc |
Sintesis estereoselectiva de activos que contienen fosforo
|
EP2555622A4
(de)
|
2010-04-09 |
2013-09-18 |
Enanta Pharm Inc |
Hemmer des hepatitis-c-virus
|
US9125904B1
(en)
|
2010-05-11 |
2015-09-08 |
Achillion Pharmaceuticals, Inc. |
Biphenyl imidazoles and related compounds useful for treating HCV infections
|
US20110312996A1
(en)
*
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
CA2800509A1
(en)
*
|
2010-05-24 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
US8778938B2
(en)
|
2010-06-04 |
2014-07-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
NZ605440A
(en)
*
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
AR081691A1
(es)
|
2010-06-28 |
2012-10-10 |
Vertex Pharma |
Derivados de tiofeno, metodos para su preparacion y su uso en el tratamiento o la prevencion de infecciones por flavivirus
|
WO2012006060A1
(en)
|
2010-06-28 |
2012-01-12 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flavivirus infections
|
US20130157894A1
(en)
*
|
2010-07-16 |
2013-06-20 |
Jin-Hua Sun |
Methods to identify combinations of ns5a targeting compound that act synergistically to inhibit hepatitis c virus replication
|
AU2011286276A1
(en)
|
2010-07-26 |
2013-01-24 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
PL2598498T3
(pl)
|
2010-07-26 |
2014-12-31 |
Janssen Sciences Ireland Uc |
Hetero-bicykliczne pochodne jako inhibitory HCV
|
US20120196794A1
(en)
*
|
2010-08-06 |
2012-08-02 |
Bristol-Myers Squibb Company |
Combinations of Hepatitis C Virus Inhibitors
|
US20120195857A1
(en)
|
2010-08-12 |
2012-08-02 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
WO2012021704A1
(en)
|
2010-08-12 |
2012-02-16 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2012020036A1
(en)
|
2010-08-13 |
2012-02-16 |
F. Hoffmann-La Roche Ag |
Hepatitis c virus inhibitors
|
WO2012024363A2
(en)
|
2010-08-17 |
2012-02-23 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flaviviridae viral infections
|
EP2963034A1
(de)
*
|
2010-08-26 |
2016-01-06 |
RFS Pharma, LLC. |
Potente und selektive inhibitoren des hepatitis-c-virus
|
WO2012040389A2
(en)
|
2010-09-22 |
2012-03-29 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic hcv inhibitors
|
EP2619195A1
(de)
*
|
2010-09-24 |
2013-07-31 |
Bristol-Myers Squibb Company |
Hemmer des hepatitis-c-virus
|
US9254292B2
(en)
|
2010-09-29 |
2016-02-09 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
EA201390532A1
(ru)
|
2010-10-08 |
2013-09-30 |
Новартис Аг |
Композиции сульфамидых ингибиторов ns3, содержащие витамин е
|
AU2014203655B2
(en)
*
|
2010-10-13 |
2016-07-07 |
Abbvie Ireland Unlimited Company |
Anti-viral compounds
|
MY164064A
(en)
*
|
2010-10-13 |
2017-11-15 |
Abbvie Bahamas Ltd |
Anti-viral compounds
|
WO2012048421A1
(en)
*
|
2010-10-14 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
MX2013004655A
(es)
|
2010-10-26 |
2013-08-27 |
Presidio Pharmaceuticals Inc |
Inhibidores del virus de la hepatitis c.
|
CN103189371B
(zh)
|
2010-11-04 |
2015-04-01 |
施万生物制药研发Ip有限责任公司 |
丙型肝炎病毒抑制剂
|
SG10201509456SA
(en)
|
2010-11-17 |
2015-12-30 |
Gilead Pharmasset Llc |
Antiviral compounds
|
JP6069215B2
(ja)
|
2010-11-30 |
2017-02-01 |
ギリアド ファーマセット エルエルシー |
化合物
|
RU2452735C1
(ru)
|
2010-11-30 |
2012-06-10 |
Александр Васильевич Иващенко |
Замещенные азолы, противовирусный активный компонент, фармацевтическая композиция, способ получения и применения
|
WO2012083048A2
(en)
*
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
US20150031884A1
(en)
*
|
2010-12-15 |
2015-01-29 |
Abbvie Inc. |
Anti-viral compounds
|
WO2012087976A2
(en)
*
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
CA2822357A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbvie Inc. |
Hepatitis c inhibitors and uses thereof
|
US8552047B2
(en)
|
2011-02-07 |
2013-10-08 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2012123298A1
(en)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
US8835456B1
(en)
|
2011-03-18 |
2014-09-16 |
Achillion Pharmaceuticals, Inc. |
NS5A inhibitors useful for treating HCV
|
US9546160B2
(en)
|
2011-05-12 |
2017-01-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
EP2709455A4
(de)
|
2011-05-18 |
2014-11-05 |
Enanta Pharm Inc |
Verfahren zur herstellung von 5-azaspiro-[2.4-]heptan-6-carbonsäure und derivaten davon
|
CN103561739B
(zh)
|
2011-05-27 |
2016-03-02 |
艾其林医药公司 |
可用于治疗hcv感染的经取代的脂肪芬、环芬、异芬、杂芬、杂-异芬以及金属茂
|
WO2012175581A1
(en)
|
2011-06-24 |
2012-12-27 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
TW201317223A
(zh)
|
2011-07-26 |
2013-05-01 |
Vertex Pharma |
噻吩化合物
|
WO2013016499A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Methods for preparation of thiophene compounds
|
EP2747569A4
(de)
*
|
2011-08-24 |
2015-07-08 |
Glaxosmithkline Llc |
Kombinationsbehandlungen für hepatitis c
|
WO2013030750A1
(en)
|
2011-09-01 |
2013-03-07 |
Lupin Limited |
Antiviral compounds
|
EP2755981A4
(de)
|
2011-09-14 |
2015-03-25 |
Merck Sharp & Dohme |
Silylhaltige heterocyclische derivate sowie verfahren zu ihrer verwendung zur behandlung von virenerkrankungen
|
UA116087C2
(uk)
|
2011-09-16 |
2018-02-12 |
Гіліад Фармассет Елелсі |
Композиція для лікування вірусу гепатиту c
|
GB201116559D0
(en)
*
|
2011-09-26 |
2011-11-09 |
Univ Leuven Kath |
Novel viral replication inhibitors
|
CN103917541B
(zh)
|
2011-10-10 |
2016-08-17 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒化合物
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
ES2527544T1
(es)
|
2011-10-21 |
2015-01-26 |
Abbvie Inc. |
Tratamiento mono (PSI-7977) o de combinación con AAD para su uso en el tratamiento del VHC
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
AR088463A1
(es)
|
2011-10-21 |
2014-06-11 |
Abbvie Inc |
Metodos para el tratamiento de hcv
|
BR112014010401A8
(pt)
*
|
2011-11-03 |
2017-12-19 |
Theravance Inc |
Inibidores do vírus da hepatite c rod-like que contêm o fragmento {2-[4-(bifenil-4-il)-1h-imidazo-2-il] pirrolidina-1-carbonilmetil}amina
|
PL3431477T3
(pl)
|
2011-11-16 |
2021-04-06 |
Gilead Pharmasset Llc |
Skondensowane imidazoliloimidazole jako związki przeciwwirusowe
|
CA2856522C
(en)
|
2011-11-22 |
2020-10-27 |
The Regents Of The University Of California |
Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa)
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
CN103987723B
(zh)
|
2011-12-16 |
2017-03-01 |
弗·哈夫曼-拉罗切有限公司 |
Hcv ns5a 的抑制剂
|
AU2012357986B2
(en)
|
2011-12-20 |
2017-02-02 |
Riboscience Llc |
4'-Azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
|
AU2012357940B2
(en)
|
2011-12-20 |
2017-02-16 |
Riboscience Llc |
2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
|
RU2621734C1
(ru)
*
|
2011-12-28 |
2017-06-07 |
Янссен Сайенсиз Айрлэнд Юси |
Гетеробициклические производные в качестве ингибиторов hcv
|
CA2858646A1
(en)
|
2011-12-28 |
2013-07-04 |
Janssen R&D Ireland |
Quinazolinone derivatives as hcv inhibitors
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
US9326973B2
(en)
*
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US9073943B2
(en)
|
2012-02-10 |
2015-07-07 |
Lupin Limited |
Antiviral compounds with a dibenzooxaheterocycle moiety
|
EP2817291A1
(de)
|
2012-02-24 |
2014-12-31 |
F. Hoffmann-La Roche AG |
Antivirale verbindungen
|
US9012427B2
(en)
|
2012-03-22 |
2015-04-21 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
CN104302636B
(zh)
|
2012-04-25 |
2017-03-29 |
施万生物制药研发Ip有限责任公司 |
C型肝炎病毒抑制剂
|
CA2869640C
(en)
|
2012-04-25 |
2018-03-20 |
Theravance Biopharma R&D Ip, Llc |
Piperazine-piperidine compounds as hepatitis c virus inhibitors
|
US8883135B2
(en)
|
2012-05-03 |
2014-11-11 |
Theravance Biopharma R&D Ip, Llc |
Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20140010783A1
(en)
|
2012-07-06 |
2014-01-09 |
Hoffmann-La Roche Inc. |
Antiviral compounds
|
CN104884455B
(zh)
*
|
2012-10-24 |
2017-09-12 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂
|
KR20150109451A
(ko)
|
2013-01-23 |
2015-10-01 |
에프. 호프만-라 로슈 아게 |
항바이러스성 트라이아졸 유도체
|
KR20140119012A
(ko)
|
2013-01-31 |
2014-10-08 |
길리어드 파마셋 엘엘씨 |
두 항바이러스 화합물의 병용 제형물
|
RU2507201C1
(ru)
|
2013-02-07 |
2014-02-20 |
Александр Васильевич Иващенко |
Алкил [(s)-1-((s)-2-{5-[4-(4-{2-[(s)-1-((s)-2-метоксикарбониламино-3-метил-бутирил)-пирролидин-2-ил]-3н-имидазол-4-ил}-бута-1,3-диинил)-фенил]-1н-имидазол-2-ил}-пирролидин-1-карбонил)-2-метил-пропил]-карбамат нафталин-1,5-дисульфонат, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
RU2015136256A
(ru)
|
2013-03-05 |
2017-04-10 |
Ф. Хоффманн-Ля Рош Аг |
Противовирусные соединения
|
US11484534B2
(en)
|
2013-03-14 |
2022-11-01 |
Abbvie Inc. |
Methods for treating HCV
|
WO2014144547A2
(en)
|
2013-03-15 |
2014-09-18 |
The Regents Of The University Of California |
Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
|
WO2014144836A2
(en)
|
2013-03-15 |
2014-09-18 |
The Regents Of The University Of California |
Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
|
EP2990406B1
(de)
|
2013-04-26 |
2018-12-26 |
Seoul National University R&DB Foundation |
Benzidinderivat, verfahren zur herstellung davon und pharmazeutische zusammensetzung mit dem benzidinderivat zur behandlung von durch das hepatitis-c-virus verursachten lebererkrankungen
|
EA201592185A1
(ru)
|
2013-05-16 |
2016-05-31 |
Рибосайенс Ллк |
4'-азидо, 3'-дезокси-3'-фторзамещенные нуклеозидные производные
|
MA46490A1
(fr)
|
2013-05-16 |
2021-04-30 |
Riboscience Llc |
Dérivés de nucléosides 4'- fluoro-2' - méthyle substitués
|
US20180200280A1
(en)
|
2013-05-16 |
2018-07-19 |
Riboscience Llc |
4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
|
US9717712B2
(en)
|
2013-07-02 |
2017-08-01 |
Bristol-Myers Squibb Company |
Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
|
US20150023913A1
(en)
|
2013-07-02 |
2015-01-22 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
CN105517574B
(zh)
*
|
2013-07-09 |
2019-01-18 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂的组合产品
|
JP2016525114A
(ja)
*
|
2013-07-17 |
2016-08-22 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
C型肝炎ウイルスの治療に使用するためのトリシクロヘキサデカヘキサエン誘導体を含む組み合わせ
|
JP2016527232A
(ja)
*
|
2013-07-17 |
2016-09-08 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
Hcvの治療に使用するためのビフェニル誘導体を含む組み合わせ
|
ES2900570T3
(es)
|
2013-08-27 |
2022-03-17 |
Gilead Pharmasset Llc |
Formulación de combinación de dos compuestos antivirales
|
KR101561964B1
(ko)
|
2013-11-15 |
2015-10-20 |
한국과학기술연구원 |
옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
|
EP3080104A1
(de)
|
2013-12-11 |
2016-10-19 |
Bristol-Myers Squibb Company |
4,4'-biphenyldiyl-bis-(1-h-imidazolyl)-derivate als hepatitis-hcv-hemmer
|
WO2015089810A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
WO2015103490A1
(en)
|
2014-01-03 |
2015-07-09 |
Abbvie, Inc. |
Solid antiviral dosage forms
|
PE20170206A1
(es)
*
|
2014-04-04 |
2017-04-09 |
X-Rx Inc |
Inhibidores espirociclicos sustituidos de la autotaxina
|
WO2015184644A1
(zh)
*
|
2014-06-06 |
2015-12-10 |
爱博新药研发(上海)有限公司 |
抑制丙肝病毒的化合物、药物组合物及其应用
|
TWI721947B
(zh)
|
2014-06-11 |
2021-03-21 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物的固態形式
|
CN106715270B
(zh)
|
2014-07-08 |
2019-02-26 |
吉玛股份公司 |
填充用于提取或浸泡饮料的一次性囊体的容纳元件的单元和方法
|
WO2016075588A1
(en)
*
|
2014-11-11 |
2016-05-19 |
Sun Pharmaceutical Industries Limited |
Stable amorphous daclatasvir dihydrochloride
|
WO2016089814A1
(en)
|
2014-12-02 |
2016-06-09 |
Concert Pharmaceuticals, Inc. |
Deuterated analogues of daclatasvir
|
CN105753944B
(zh)
*
|
2014-12-19 |
2019-10-01 |
正大天晴药业集团股份有限公司 |
达卡他韦及其衍生物的制备中间体
|
WO2016102979A1
(en)
|
2014-12-26 |
2016-06-30 |
Cipla Limited |
Polymorphic forms of methyl((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl)carbamate and salts thereof
|
CN106188015B
(zh)
*
|
2015-05-06 |
2019-10-18 |
广东东阳光药业有限公司 |
一种制备达卡他韦的方法
|
WO2016178250A1
(en)
|
2015-05-07 |
2016-11-10 |
Mylan Laboratories Limited |
Process for the preparation of daclatasvir
|
CZ2015366A3
(cs)
|
2015-05-29 |
2016-12-07 |
Zentiva, K.S. |
Pevné formy Daclatasviru
|
US20160375017A1
(en)
|
2015-06-26 |
2016-12-29 |
Abbvie Inc. |
Solid Pharmaceutical Compositions for Treating HCV
|
US10617675B2
(en)
|
2015-08-06 |
2020-04-14 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2017076358A1
(zh)
*
|
2015-11-06 |
2017-05-11 |
苏州晶云药物科技有限公司 |
咪唑基联苯基化合物盐的新晶型及其制备方法
|
GB2552919A
(en)
*
|
2015-11-18 |
2018-02-21 |
Azad Pharmaceutical Ingredients Ag |
Stable amorphous form of daclatasvir
|
CN106083829B
(zh)
*
|
2016-01-12 |
2019-01-22 |
深圳市塔吉瑞生物医药有限公司 |
一种丙型肝炎病毒抑制剂、药物组合物及其应用
|
WO2017172476A1
(en)
*
|
2016-03-28 |
2017-10-05 |
The University Of Toledo |
Potent inhibitors of aspartate n-acetyl-transferase for the treatment of canavan disease
|
KR102527786B1
(ko)
|
2016-04-07 |
2023-04-28 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
단백질 조정제로서 유용한 헤테로시클릭 아미드
|
WO2017189978A1
(en)
|
2016-04-28 |
2017-11-02 |
Emory University |
Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
|
WO2018007984A1
(en)
|
2016-07-08 |
2018-01-11 |
Lupin Limited |
Crystalline forms of daclatasvir dihydrochloride
|
US20190337932A1
(en)
*
|
2016-07-18 |
2019-11-07 |
Gienmark Pharmaceuticals Limited |
Process for preparation of daclatasvir and salts
|
CN108069941A
(zh)
*
|
2016-11-15 |
2018-05-25 |
广东东阳光药业有限公司 |
一种制备达卡他韦的方法
|
RU2650610C1
(ru)
|
2017-02-28 |
2018-04-16 |
Васильевич Иващенко Александр |
Противовирусная композиция и способ ее применения
|
US10392370B2
(en)
*
|
2017-03-13 |
2019-08-27 |
Optimus Drugs Pvt Ltd |
Process for the preparation of Daclatasvir dihydrochloride and its intermediates
|
WO2018171660A1
(zh)
|
2017-03-22 |
2018-09-27 |
正大天晴药业集团股份有限公司 |
用于抗丙型肝炎病毒感染的含硅化合物
|
CN109305962B
(zh)
*
|
2017-07-28 |
2022-01-18 |
扬子江药业集团有限公司 |
一种盐酸达拉他韦的精制方法
|
AR112702A1
(es)
|
2017-09-21 |
2019-11-27 |
Riboscience Llc |
Derivados de nucleósidos sustituidos con 4-fluoro-2-metilo como inhibidores de la replicación de hcv arn
|
US20220099637A1
(en)
|
2018-12-04 |
2022-03-31 |
Bristol-Myers Squibb Company |
Methods of analysis using in-sample calibration curve by multiple isotopologue reaction monitoring
|
TW202106677A
(zh)
*
|
2019-04-25 |
2021-02-16 |
美商貝達醫藥公司 |
用於治療c型肝炎病毒感染之ns5a的二胺甲酸酯抑制劑
|
JP2024519910A
(ja)
|
2021-05-21 |
2024-05-21 |
ギリアード サイエンシーズ, インコーポレイテッド |
ジカウイルス阻害剤としての五環式誘導体
|
WO2024059005A1
(en)
*
|
2022-09-14 |
2024-03-21 |
Jnana Therapeutics Inc. |
Treating pku with correctors of mammalian slc6a19 function
|